Categories: HardwareHealthTechHumanMedtechVirtual
adsilico is developing an end-to-end in-silico trials solution based on virtual ‘synthetic patient populations that will provide better and safer medical devices earlier to patients, reduce costs and accelerate R&D timescales for medical device developers, contribute to animal welfare by reducing animal experimentation, reducing refining and partially replacing costly and potentially harmful human trials.
Investors 1
Funding Rounds 1
| Date | Series | Amount | Investors |
| 26.02.2024 | - | $4.44M | - |
Mentions in press and media 2
| Date | Title | Description |
| 26.02.2024 | adsilico – raises £3.5m funding round | Delighted to announce our investment into adsilico as part of a £3.5m seed funding round, as seen in The Times today. The University of Leeds spin-out is a ground-breaking computational medicine company, developing an end-to-end in-silico t... |
| - | Adsilico | “adsilico” |
Reviews 0
